A new portal for patient data
J Kaiser - 2018 - science.org
A new portal for patient data | Science news careers commentary Journals Science Science
brought to you byGoogle Indexer Log in science science advances science immunology science …
brought to you byGoogle Indexer Log in science science advances science immunology science …
From patient to patient—sharing the data from clinical trials
CJ Haug - New England Journal of Medicine, 2016 - Mass Medical Soc
In the face of general agreement that sharing clinical trials data is important, an
interdisciplinary meeting addressed such questions as how and how much to share, where …
interdisciplinary meeting addressed such questions as how and how much to share, where …
[PDF][PDF] Moving data sharing forward: the launch of the Vivli platform
R Li, J Scott, F Rockhold, I Sim, J Wood - 2018 - hra.figshare.com
Moving Data Sharing Forward.indd Page 1 Moving Data Sharing Forward: The Launch of
the Vivli Platform Rebecca Li, PhD, Vivli; Jessica Scott, MD, JD, GlaxoSmithKline; Frank …
the Vivli Platform Rebecca Li, PhD, Vivli; Jessica Scott, MD, JD, GlaxoSmithKline; Frank …
Protecting patient privacy when sharing patient-level data from clinical trials
K Tucker, J Branson, M Dilleen, S Hollis… - BMC medical research …, 2016 - Springer
Background Greater transparency and, in particular, sharing of patient-level data for further
scientific research is an increasingly important topic for the pharmaceutical industry and …
scientific research is an increasingly important topic for the pharmaceutical industry and …
More transparency for clinical trial data: the decision by the European Medicines Agency to make clinical trial reports publicly available could provide a boon for …
P Hunter - EMBO reports, 2015 - embopress.org
details about commercially sensitive data, the real problem for granting unfettered access to
clinical trial data is patient confidentiality. EMA and other regulatory bodies were still …
clinical trial data is patient confidentiality. EMA and other regulatory bodies were still …
Access to patient-level trial data—a boon to drug developers
HG Eichler, F Pétavy, F Pignatti… - New England Journal of …, 2013 - Mass Medical Soc
Access to Patient-Level Trial Data — A Boon to Drug Developers | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Clinical trial data sharing: here's the challenge
Objective Anonymised patient-level data from clinical research are increasingly recognised
as a fundamental and valuable resource. It has value beyond the original research project …
as a fundamental and valuable resource. It has value beyond the original research project …
[PDF][PDF] EMA Policy 0070: Data Utility in Anonymised Clinical Study Reports (CSRs)
JM Ferran, Q ApS… - Data Utility in …, 2017 - phuse.s3.eu-central-1.amazonaws …
EMA Policy 0070: Data Utility in Anonymised Clinical Study Reports (CSRs) Page 1 PhUSE
2017 1 Paper DH04 EMA Policy 0070: Data Utility in Anonymised Clinical Study Reports (CSRs) …
2017 1 Paper DH04 EMA Policy 0070: Data Utility in Anonymised Clinical Study Reports (CSRs) …
Researchers oppose data-sharing proposal
T Murray - 2016 - Can Med Assoc
Medicine. They were responding to the proposal published in January by the International
Committee of Medical Journal Editors (ICMJE) that, as a condition of publication and as part …
Committee of Medical Journal Editors (ICMJE) that, as a condition of publication and as part …
Publishing descriptions of non-public clinical datasets: proposed guidance for researchers, repositories, editors and funding organisations
Sharing of experimental clinical research data usually happens between individuals or
research groups rather than via public repositories, in part due to the need to protect …
research groups rather than via public repositories, in part due to the need to protect …